Core Viewpoint - The article highlights the emergence of female fund managers in the pharmaceutical sector, particularly during the current innovative drug market boom, showcasing their impressive performance and unique investment strategies [3][6][18]. Group 1: Performance of Female Fund Managers - Zhang Wei, known as the "new pharmaceutical queen," leads the market with her fund, achieving a maximum return of 176.96% this year, with a current return of 142.74% as of October 13 [3][11]. - Other notable female fund managers, such as Ge Lan, Zhao Bei, and Tan Xiaobing, have also excelled, with their funds ranking high in performance, reflecting diverse investment philosophies in the innovative drug sector [5][18]. - The overall performance of these fund managers indicates a strong recovery in the innovative drug market after a prolonged downturn [7][18]. Group 2: Investment Strategies - Zhang Wei's investment strategy focuses on large-cap stocks in the pharmaceutical sector, with 90.83% of her portfolio allocated to pharmaceutical and biotechnology companies, reflecting a significant increase of 28.55% from the previous period [11][15]. - Ge Lan emphasizes cross-border collaborations and clinical expectations, actively participating in private placements to enhance risk-reward ratios [28][29]. - Zhao Bei adopts a more conservative approach, diversifying her portfolio to include both innovative and traditional pharmaceutical companies, aiming to balance risk and growth [31][32]. Group 3: Market Dynamics and Future Outlook - The article notes a significant divergence in the performance and scale of pharmaceutical funds, with some funds experiencing a decline in assets despite strong returns, indicating a shift in investor behavior [19][23]. - The innovative drug sector is expected to enter a growth phase, driven by supportive policies, increased international transactions, and a projected surge in revenue for innovative drug companies by 2025 [35][36][41]. - The article concludes that the current favorable conditions for innovative drugs will likely sustain for the next two to three years, providing a platform for fund managers to implement their diverse investment strategies [43][44].

Group 1: Shunluo Electronics - Shunluo Electronics has made significant progress in data centers, automotive electronics, and mobile communications [1] - The data center market is experiencing strong growth, with significant order increases expected in the first half of 2025 [1] - Automotive electronics have achieved comprehensive coverage in electrification scenarios, extending to intelligent driving and smart cockpit applications [1] - The mobile communications sector remains a traditional stronghold, with AI applications driving demand for power management products [1] - The company has a healthy order backlog, with high capacity utilization across different business lines [1] - The gross margin is expected to remain stable and above industry average levels [1] Group 2: Shijia Photonics - Shijia Photonics has made advancements in multiple business segments, including the mass production of 800G/1.6T optical modules [1] - The company is progressing with its expansion plans for MPO products, focusing on factory planning, equipment installation, and personnel training [1] - Inventory growth is attributed to strategic stocking of key raw materials and increased reserves of general materials and semi-finished products [1] - Capital expenditures are rising due to increased R&D investments, capacity expansion, and overseas layout [1] Group 3: Chongda Technology - Chongda Technology anticipates positive growth in the global PCB market by 2025, with strong order demand and rising product prices [2] - The company has an 85% capacity utilization rate and is expanding production with new facilities in Zhuhai and Thailand [2] - To improve profitability, the company is focusing on high-value customers, optimizing sales structure, and enhancing cost management [2] - The company is implementing a structural price increase strategy to counter rising raw material costs [2] - The U.S. market accounts for 10% of revenue, and the company is diversifying its market and optimizing customer collaborations to adapt to tariff policy changes [2] Group 4: Changcheng Fund - Changcheng Fund, established in 2001, has an asset management scale of 347.694 billion yuan, ranking 29th among 210 [2] - The fund's non-monetary public fund management scale is 139.427 billion yuan, ranking 37th among 210 [2] - The fund manages 237 public funds, ranking 27th among 210, with 37 fund managers, ranking 32nd among 210 [2] - The best-performing public fund product in the past year is Changcheng Health Mixed A, with a net value of 1.2 and a growth of 98.74% [2]

Report Industry Investment Rating Not provided in the content Core Viewpoints - This week (from July 14 to July 18, 2025), among various types of fund products, active equity funds had the highest weekly average return rate of 3.00%. The other types of funds, ranked by their weekly average return rates from high to low, were QDII funds (2.45%), ETF funds (1.81%), quantitative funds (1.48%), FOF funds (0.55%), bond funds (0.19%), and REITs funds (0.08%) [2][8]. - Year - to - date, REITs funds led with an average increase of 19.07%. The other types of funds, ranked by their return rates from high to low, were QDII funds (17.11%), active equity funds (11.94%), quantitative funds (9.79%), ETF funds (9.75%), FOF funds (4.94%), and bond funds (1.71%) [8]. Summary by Directory 1. Cross - Category Fund Product Return Overview - Selected funds for statistical analysis had a scale of over 0.1 billion yuan at the end of the latest reporting period and were established before 2025. This week, active equity funds had the highest weekly average return rate of 3.00%. Year - to - date, REITs funds led with an average increase of 19.07% [8]. 2. Active Equity Funds 2.1 Performance of Major Broad - Based Indexes in A - share and Hong Kong Markets - This week, all major broad - based indexes in the A - share market except the BeiZheng 50 index rose, with the overall increase slightly lower than last week. The ChiNext Index had the best performance with a weekly change of 3.17%, followed by the Shenzhen Component Index with 2.04%. The BeiZheng 50 index had the weakest performance with a weekly change of - 0.16%. All major broad - based indexes in the Hong Kong market rose this week, with the increase significantly higher than last week. The Hang Seng Index and the Hang Seng Tech Index had changes of 2.84% and 5.53% respectively [11]. 2.2 Performance of Shenwan Primary Industry Indexes - Most Shenwan primary industry indexes rose this week. The communication, pharmaceutical biology, and automobile industry indexes performed relatively well, with weekly changes of 7.56%, 4.00%, and 3.28% respectively. The public utilities, real estate, and media industry indexes performed weakly, with weekly changes of - 1.37%, - 2.17%, and - 2.24% respectively [13]. 2.3 Overview of Returns of High - Performing Active Equity Funds - This week, the overall average return rate of active equity funds was 3.00%. Great Wall Health Mix A had the best performance with a weekly return rate of 16.27%, driven by the launch of the national drug procurement and the total License - out amount approaching 66 billion yuan in the first half of the year. High - performing funds mostly had heavy positions in industries such as pharmaceutical biology and communication [15]. 2.4 Overview of Returns of Industry - Specific Active Equity Funds - This week, the average return rate of industry - specific active equity funds was 5.15%, significantly better than the overall level of active equity funds. Pharmaceutical industry funds performed brightly this week with an average return rate of 8.54%. TMT industry funds had a weekly average return rate of 4.86%. Financial real - estate industry funds had a relatively weak performance with a weekly average return rate of 0.03% [18]. 2.5 Overview of Returns of Non - Industry Active Equity Funds - This week, the average return rate of non - industry funds was 2.72%, slightly weaker than the overall level of active equity funds. The growth - style funds were relatively dominant this week with a weekly average return rate of 3.58% [21]. 3. Quantitative Funds 3.1 Overview of Quantitative Fund Returns - This week, the average return rate of quantitative funds was 1.48%. Huaxia CSI All - Share Pharmaceutical and Healthcare Enhanced had the highest weekly return rate of 8.83%. In terms of strategy types, active quantitative funds had the best weekly average return of 1.66% [23]. 3.2 Overview of Returns of Major Index - Enhanced Quantitative Funds - This week, among index - enhanced quantitative funds, funds tracking the Guozheng 2000 index performed better with an average return rate of 1.69%. The weekly average return rates of funds tracking the CSI 300, CSI 500, and CSI 1000 indexes were 1.10%, 1.06%, and 1.44% respectively. The proportion of funds achieving positive excess returns was 58.72%, slightly higher than last week [25]. 4. Bond Funds 4.1 Performance of Major Bond Indexes - This week, major bond market indexes generally rose. The CSI Aggregate Bond Index rose 0.11% to close at 261.42, the CSI Treasury Bond Index rose 0.04% to close at 247.89, and the CSI Credit Bond Index rose 0.08% to close at 214.00 [27]. 4.2 Performance of Convertible Bond Indexes - This week, the CSI Convertible Bond Index rose 0.67% to close at 453.86, with the weekly trading volume increasing by 3.75%. The median convertible bond price rose 1.07% to close at 127.55, and the median conversion premium rate rose 0.25% to 26.52% [30]. 4.3 Overview of Bond Fund Returns - This week, the average return rate of bond funds was 0.19%. Huashang Shuangyi Balance Mix A had the best performance with a weekly return rate of 5.09%. High - performing bond funds were mostly partial - debt hybrid, convertible bond, and hybrid bond funds [32]. 4.4 Overview of Returns of Pure - Bond Funds - This week, the average return rate of pure - bond funds was 0.07%. The return rates of short - term and medium - long - term pure - bond funds were 0.05% and 0.07% respectively. Huatai Zijin Zhihe Interest - Rate Bond performed relatively best with a weekly average return rate of 1.90% [34]. 4.5 Overview of Returns of Hybrid Bond Funds - This week, the weekly average return rate of hybrid bond funds was 0.26%. The return rates of hybrid bond - type level - 1 and level - 2 funds were 0.14% and 0.35% respectively. Golden Eagle Yuanfeng Bond A performed best with a weekly average return rate of 3.07% [37]. 4.6 Overview of Returns of Partial - Debt Hybrid and Flexible Allocation Bond Funds - This week, the average return rate of partial - debt hybrid bond funds was 0.49%, and that of flexible allocation bond funds was 0.30%. Huashang Shuangyi Balance Mix A performed best with a weekly return rate of 5.09% [39]. 4.7 Overview of Returns of Convertible Bond Funds - This week, the average return rate of convertible bond funds was 1.09%. Southern Changyuan Convertible Bond A performed best with a weekly average return rate of 2.42% [41]. 5. ETF Funds 5.1 Overview of ETF Fund Fund Flows - This week, ETF funds had a net inflow of 56.265 billion yuan, a 265.37% increase compared to the previous period. Except for bond - type and cross - border ETFs, which had net inflows, other types of ETFs had net outflows. Bond - type ETFs had a large - scale net inflow of 73.367 billion yuan, reaching a historical high. Stock - type ETFs had a net outflow of 17.072 billion yuan [43]. 5.2 Overview of ETF Funds with Top Net Inflows by Index - Among the tracked indexes, ETFs tracking the AAA Sci - tech Innovation Bond and Shanghai AAA Sci - tech Innovation Bond indexes in the bond index had the top net inflows, with 48.339 billion yuan and 18.073 billion yuan respectively. Among the equity indexes, ETFs tracking the securities company, Hong Kong securities, and Sci - tech Innovation 50 indexes had relatively large net inflows [47]. 5.3 Overview of ETF Funds with Top Net Outflows by Index - This week, the tracked indexes with top net outflows were all equity indexes, including the CSI A500 index (10.228 billion yuan), the CSI 300 index (7.175 billion yuan), the ChiNext Index (2.904 billion yuan), the CS Artificial Intelligence index (2.410 billion yuan), and the CSI 1000 index (2.235 billion yuan) [50]. 5.4 Overview of ETF Funds with Top Net Inflows - This week, most of the ETFs with top net inflows were Sci - tech Innovation Bond ETFs. Huaxia Sci - tech Innovation Bond ETF had the largest net inflow of 12.296 billion yuan, followed by Harvest Sci - tech Innovation Bond ETF with a net inflow of 11.324 billion yuan. Hong Kong Securities ETF also had a relatively large net inflow of 24.63 billion yuan this week [52]. 5.5 Overview of ETF Funds with Top Net Outflows - This week, most of the ETFs with top net outflows were scale - index ETFs. YinHua RiLi ETF had the largest net outflow of 3.632 billion yuan. Among the scale - index ETFs, CSI 300 ETF had a relatively large net outflow of 3.252 billion yuan. In addition, the Artificial Intelligence ETF in the theme - index ETF also had a relatively large net outflow [54]. 5.6 Overview of Returns of High - Performing ETF Funds - This week, the overall average change rate of ETF funds was 1.81%. Hang Seng Innovative Drug ETF had the highest weekly increase of 13.69%. High - performing ETF funds were mostly cross - border ETFs with investment themes such as innovative drugs. In addition, the ChiNext Artificial Intelligence ETF (Fullgoal) in the theme - index ETF also had a relatively high increase of 10.95% [56]. 6. FOF Funds - This week, the average return rate of FOF funds was 0.55%. Bank of Communications Smart Selection Starlight Mix (FOF - LOF) A had the best performance with a weekly return rate of 5.11%. Among the types, stock - type FOF funds performed best with an average return rate of 1.80% [57]. 7. QDII Funds - This week, the overall average return rate of QDII funds was 2.45%. Huatai - PineBridge Hong Kong Advantage Select Mix (QDII) A had the highest weekly return rate of 15.89%. The average return rates of different types of QDII funds were: stock - type 2.71%, hybrid - type 3.41%, bond - type - 0.04%, and other - type - 0.38% [60]. 8. REITs Funds - This week, the average change rate of REITs funds was 0.08%. China Merchants Sci - tech Innovation REIT had the best performance with a weekly change rate of 3.05% [62].

- The report does not contain any specific quantitative models or factors for analysis, construction, or testing results [1][2][3]

Group 1 - The core viewpoint of the news is that 热景生物 (688068.SH) has reported its Q1 2025 financial results, highlighting significant institutional investor interest and changes in shareholding patterns [1] - As of April 30, 2025, a total of 55 institutional investors hold shares in 热景生物, with a combined holding of 28.6952 million shares, representing 31.03% of the total share capital [1] - The top ten institutional investors collectively hold 23.88% of the shares, with an increase of 1.63 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 18 funds increased their holdings in this period, with a total increase rate of 3.19%, including funds like 易方达医药生物股票A and 农银医疗保健股票 [2] - Conversely, 11 funds reduced their holdings, with a decrease rate of 0.54%, including funds like 富国精准医疗灵活配置混合A and 招商景气优选股票A [2] - There were 16 newly disclosed public funds this period, while 107 funds were not disclosed compared to the previous quarter [2]